Therefore, although liver fat accumulation is a benign stage of NAFLD, the elevated plasma Fgf21 likely indicated vulnerability to metabolic stressors that may contribute towards progression to end-stage NAFLD. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.